Amylyx Pharmaceuticals, Inc. (AMLX) stock
AMLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$27.52−0.28 (-1.01%)
Close on Nov 17, 2026Market cap $3.07BP/E –Yield –
Amylyx Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Amylyx Pharmaceuticals's price to book ratio was 14.8× on Nov 11, 2026, against 5.0× a year earlier. Over the last 5 years it ranged from 0.3× to 15.9×, with a median of 4.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 14.8× | +10.8 |
| 2025 | Dec 31, 2025 | 4.0× | +2.7 |
| 2024 | Dec 31, 2024 | 1.3× | −1.1 |
| 2023 | Dec 29, 2023 | 2.4× | −12.6 |
| 2022 | Dec 30, 2022 | 15.0× | – |
See a number that looks wrong?